Brief: Kiromic Biopharma Announces Reverse Stock Split
10/03/2023 21:32
March 10 (Reuters) - Kiromic Biopharma Inc KRBP.O :
* KIROMIC BIOPHARMA ANNOUNCES REVERSE STOCK SPLIT
* KIROMIC BIOPHARMA INC - WILL EFFECT REVERSE STOCK SPLIT OF
OUTSTANDING SHARES OF COMMON STOCK AT A RATIO OF 1-FOR-30
* KIROMIC BIOPHARMA INC - COMMON STOCK WILL BEGIN TRADING ON
SPLIT-ADJUSTED BASIS WHEN MARKET OPENS ON MARCH 13 UNDER
EXISTING TRADING SYMBOL KRBP
Source text for Eikon: ID:nBw6PKNTJa
Further company coverage: KRBP.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Kiromic Biopharma
See all newsBrief: Kiromic Biopharma Files For Offering Up To 1 Million Units
Brief: Kiromic Biopharma Applies To List Common Stock On The NYSE American Under Symbol 'KRBP'
Brief: Kiromic Biopharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation
Brief: Kiromic Biopharma Reports Favorable Results At Six Weeks From Fourth Patient In Deltacel-01 Clinical Trial
Brief: Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site